Clinical trial
Prospective Multicenter Randomized Trial About Transanal Hemorrhoidal Dearterialization With Mucopexy (THD) Versus Ligasure Hemorrhoidectomy for Grade III and IV Hemorrhoids
NCT02654249 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Multicenter Randomized Trial About Transanal Hemorrhoidal Dearterialization With Mucopexy (THD) Versus Ligasure Hemorrhoidectomy for Grade III and IV Hemorrhoids
- Lead sponsor
- Hospital Universitari de Bellvitge
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- January 31, 2020
- Enrollment
- 80 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.